Anthony M. Hunter, MD, assistant professor, Department of Hematology and Medical Oncology, Emory University School of Medicine, medical director, Immediate Care Center, Winship Cancer Institute of Emory University, discusses the evolution of JAK inhibitors in myelofibrosis, a topic that was highlighted in a presentation at the 2023 SOHO Annual Meeting. The primary objective of the […]
TEMPE, Ariz., Oct. 26, 2023 /PRNewswire/ — GT Medical Technologies, Inc. a medical device company dedicated to improving the lives of patients with brain tumors, today announced that its FDA-cleared GammaTile® Therapy has been nominated for a Prix Galien USA 2023 Award for Best Medical Technology by the Galien Foundation. The Galien Foundation winners for this […]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Oct 26, 2023– Foundation Medicine, Inc., today announced its participation in the National Cancer Institute’s (NCI) Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH) initiative to test new therapy combinations in select groups of adults and children with cancer. NCI is part of the National Institutes of Health. Foundation Medicine […]
The US National Childhood Cancer Registry (NCCR) is combining data from myriad sources to hasten and improve research into pediatric and young adult cancers. The registry will also draw information from birth defects registries and state departments of health. The NCCR, still in early development, will gather data from the US National Cancer Institute’s existing […]
Cardiovascular disease was the number one cause of death in the Cayman Islands last year, according to the latest statistics from the Economics and Statistics Office. It was closely followed by malignant neoplasms – commonly called cancerous tumours. The recently published Cayman Islands Compendium of Statistics 2022 gave a breakdown of the deaths last year. […]
This study evaluated the performance of a DLM system in the differential diagnosis of superficial soft-tissue masses, especially its value for less experienced and experienced radiologists. The DLM-assisted diagnosis was significantly helpful for the two radiologists. DLM-1 and DLM-2 are two deep learning diagnostic models. DLM-1 was trained to distinguish between benign and malignant masses, […]
— Conference Call Scheduled for Thursday, November 2, 2023, at 8:00 a.m. ET — NEWTON, Mass., Oct. 26, 2023 /PRNewswire/ — Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced it will report third quarter 2023 financial results on Thursday, November 2, 2023. Karyopharm’s management team will host a […]
